Laboratory grade peptide formulations of GHK-Cu, produced under strict manufacturing conditions, deliver the consistency that rigorous protocols demand
Protocol 3: fat loss and body recomposition (2-3 peptides) Goal: Maximize fat loss while preserving or building lean mass Peptides: Semaglutide : Start 0.25mg weekly, titrate to 1-2.4mg weekly over 8-16 weeks BPC-157 : 250mcg twice daily (protects gut health during GLP-1 use) Optional third: Ipamorelin 100mcg twice daily (supports lean mass preservation) Why this works: Semaglutide provides powerful appetite suppression and improved insulin sensitivity for fat loss
Research Landscape Published research involving GHK-Cu, KPV, BPC-157, TB-500, and related signaling peptides has explored their roles in extracellular communication, regulatory peptide signaling, cellular migration, and structural response behavior across multiple experimental models
BPC-157 is sold strictly for laboratory research use only and is not intended for human consumption, medical use, or therapeutic application
The argument is not that a single early appointment is a strain, but that the precedent of making such exceptions could be
